- Home
- GALT vs LFMD Comparison
GALT vs LFMD Comparison
Compare GALT & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GALT | LFMD |
|---|---|---|
| Founded | 2000 | 1994 |
| Country | United States | United States |
| Employees | 9 | 384 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.0M | 236.7M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | GALT | LFMD |
|---|---|---|
| Price | $4.63 | $4.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $8.50 | ★ $9.14 |
| AVG Volume (30 Days) | ★ 1.1M | 1.1M |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.52 |
| Revenue Next Year | N/A | $18.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.03 | $2.60 |
| 52 Week High | $7.13 | $12.72 |
Technical Indicators
Market Signals| Indicator | GALT | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 72.46 | 57.62 |
| Support Level | $2.75 | $3.39 |
| Resistance Level | $5.21 | $5.24 |
| Average True Range (ATR) | 0.47 | 0.36 |
| MACD | 0.14 | 0.02 |
| Stochastic Oscillator | 80.23 | 83.54 |
Price Performance
Historical ComparisonAbout GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About LFMD LifeMD Inc.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.